Richard J. Gregory

Person

Westford, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-TGF-beta antibodies and their use
- Patent number 12,049,496
- Issue date Jul 30, 2024
- Sanofi
- Gary Shapiro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-TGF-beta antibodies and their use
- Patent number 11,242,384
- Issue date Feb 8, 2022
- Sanofi
- Gary Shapiro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-TGF-β antibodies and their use
- Patent number 10,766,955
- Issue date Sep 8, 2020
- Sanofi
- Gary Shapiro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of myocardial infarction using TGF-β antagonists
- Patent number 10,633,437
- Issue date Apr 28, 2020
- Genzyme Corporation
- Geoffrey Y. Akita
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Adenovirus vectors for gene therapy
- Patent number 7,318,919
- Issue date Jan 15, 2008
- Genzyme Corporation
- Richard Gregory
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
DNA molecules stabilized for propagation in bacterial cells that en...
- Patent number 7,118,911
- Issue date Oct 10, 2006
- Genzyme Corporation
- Richard Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of using an adenoviral vector encoding a retinoblastoma prot...
- Patent number 7,105,156
- Issue date Sep 12, 2006
- The Regents of the University of California
- Wen-Hwa Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for inducing gene expression
- Patent number 7,053,062
- Issue date May 30, 2006
- Genzyme Corporation
- Richard J. Gregory
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant adenoviral vector and method of use
- Patent number 7,041,284
- Issue date May 9, 2006
- Canji, Inc.
- Richard J. Gregory
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant adenoviral vector and methods of use
- Patent number 6,989,268
- Issue date Jan 24, 2006
- Canji, Inc.
- Richard J. Gregory
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating hyperproliferative disorders using retinoblasto...
- Patent number 6,902,731
- Issue date Jun 7, 2005
- Canji, Inc.
- Douglas Antelman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Transgene expression systems
- Patent number 6,485,720
- Issue date Nov 26, 2002
- Genzyme Corporation
- Johanne Kaplan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for inducing gene expression
- Patent number 6,432,927
- Issue date Aug 13, 2002
- Genzyme Corporation
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Retinoblastoma fusion proteins
- Patent number 6,379,927
- Issue date Apr 30, 2002
- Canji, Inc.
- Douglas Antelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transgene expression systems
- Patent number 6,358,507
- Issue date Mar 19, 2002
- Genzyme Corporation
- Johanne Kaplan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Organ-specific targeting of cationic amphiphile / DNA complexes for...
- Patent number 6,331,524
- Issue date Dec 18, 2001
- Genzyme Corporation
- Ronald K. Scheule
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant adenoviral vector and methods of use
- Patent number 6,210,939
- Issue date Apr 3, 2001
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transgene expression systems
- Patent number 6,100,086
- Issue date Aug 8, 2000
- Genzyme Corporation
- Johanne Kaplan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gene therapy for cystic fibrosis
- Patent number 6,093,567
- Issue date Jul 25, 2000
- Genzyme Corporation
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Retinoblastoma fusion polypeptides
- Patent number 6,074,850
- Issue date Jun 13, 2000
- Canji, Inc.
- Douglas Antelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Adenoviral vectors capable of facilitating increased persistence of...
- Patent number 6,020,191
- Issue date Feb 1, 2000
- Genzyme Corporation
- Abraham Scaria
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specific for cystic fibrosis transmembrane conductance r...
- Patent number 5,981,714
- Issue date Nov 9, 1999
- Genzyme Corporation
- Seng H. Cheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transgene expression system for increased persistence
- Patent number 5,981,275
- Issue date Nov 9, 1999
- Genzyme Corporation
- Donna Armentano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant adenoviral vector and methods of use
- Patent number 5,932,210
- Issue date Aug 3, 1999
- Canji Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Adenoviral vectors for gene therapy containing deletions in the ade...
- Patent number 5,882,877
- Issue date Mar 16, 1999
- Genzyme Corporation
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for producing DNA encoding cystic fibrosis transmembrane con...
- Patent number 5,876,974
- Issue date Mar 2, 1999
- Genzyme Corporation
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric adenoviral vectors
- Patent number 5,877,011
- Issue date Mar 2, 1999
- Genzyme Corporation
- Donna Armentano
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Adenovirus vector for gene therapy
- Patent number 5,670,488
- Issue date Sep 23, 1997
- Genzyme Corporation
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-TGF-BETA ANTIBODIES AND THEIR USE
- Publication number 20220195026
- Publication date Jun 23, 2022
- SANOFI
- Gary Shapiro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPIES AGAINST CANCER TARGETING CD38 AND TGF-BETA
- Publication number 20210155708
- Publication date May 27, 2021
- Francisco ADRIAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TGF-BETA ANTIBODIES AND THEIR USE
- Publication number 20200399358
- Publication date Dec 24, 2020
- Gary Shapiro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TGF-BETA ANTIBODIES AND THEIR USE
- Publication number 20180244763
- Publication date Aug 30, 2018
- SANOFI
- Gary Shapiro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS
- Publication number 20170233465
- Publication date Aug 17, 2017
- Genzyme Corporation
- Geoffrey Y. AKITA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS
- Publication number 20130330352
- Publication date Dec 12, 2013
- Genzyme Corporation
- Geoffrey Y Akita
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE
- Publication number 20090088398
- Publication date Apr 2, 2009
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20090082289
- Publication date Mar 26, 2009
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20080299083
- Publication date Dec 4, 2008
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20080182807
- Publication date Jul 31, 2008
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADENOVIRAL VECTORS HAVING A PROTEIN IX DELETION
- Publication number 20080175818
- Publication date Jul 24, 2008
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20070259429
- Publication date Nov 8, 2007
- Canji,Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Gene therapy using replication competent targeted adenoviral vectors
- Publication number 20070254357
- Publication date Nov 1, 2007
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE
- Publication number 20070253932
- Publication date Nov 1, 2007
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20070128166
- Publication date Jun 7, 2007
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diagnostic and treatment methods involving the cystic fibrosis tran...
- Publication number 20070053879
- Publication date Mar 8, 2007
- Genzyme Corporation
- Richard Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Recombinant adenoviral vector and method of use
- Publication number 20070031381
- Publication date Feb 8, 2007
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20070009486
- Publication date Jan 11, 2007
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20060275261
- Publication date Dec 7, 2006
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20060233759
- Publication date Oct 19, 2006
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20060171925
- Publication date Aug 3, 2006
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Recombinant adenoviral vectors and methods of use
- Publication number 20060140910
- Publication date Jun 29, 2006
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compositions and methods for inducing gene expression
- Publication number 20060127361
- Publication date Jun 15, 2006
- Genzyme Corporation
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20060099187
- Publication date May 11, 2006
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20060039893
- Publication date Feb 23, 2006
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20060034804
- Publication date Feb 16, 2006
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of treating diabetes and other blood sugar disorders
- Publication number 20050107318
- Publication date May 19, 2005
- Samuel Wadsworth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20050031590
- Publication date Feb 10, 2005
- Richard Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Gene therapy using replication competent targeted adenoviral vectors
- Publication number 20050002906
- Publication date Jan 6, 2005
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Adenoviral vectors having a protein IX deletion
- Publication number 20040266006
- Publication date Dec 30, 2004
- Canji, Inc.
- Richard J. Gregory
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Richard J. Gregory

Person

Patents Grantslast 30 patents

Anti-TGF-beta antibodies and their use

Anti-TGF-beta antibodies and their use

Anti-TGF-β antibodies and their use

Treatment of myocardial infarction using TGF-β antagonists

Adenovirus vectors for gene therapy

DNA molecules stabilized for propagation in bacterial cells that en...

Method of using an adenoviral vector encoding a retinoblastoma prot...

Compositions and methods for inducing gene expression

Recombinant adenoviral vector and method of use

Recombinant adenoviral vector and methods of use

Methods of treating hyperproliferative disorders using retinoblasto...

Transgene expression systems

Compositions and methods for inducing gene expression

Retinoblastoma fusion proteins

Transgene expression systems

Organ-specific targeting of cationic amphiphile / DNA complexes for...

Recombinant adenoviral vector and methods of use

Transgene expression systems

Gene therapy for cystic fibrosis

Retinoblastoma fusion polypeptides

Adenoviral vectors capable of facilitating increased persistence of...

Antibodies specific for cystic fibrosis transmembrane conductance r...

Transgene expression system for increased persistence

Recombinant adenoviral vector and methods of use

Adenoviral vectors for gene therapy containing deletions in the ade...

Method for producing DNA encoding cystic fibrosis transmembrane con...

Chimeric adenoviral vectors

Adenovirus vector for gene therapy

Patents Applicationslast 30 patents

ANTI-TGF-BETA ANTIBODIES AND THEIR USE

COMBINATION THERAPIES AGAINST CANCER TARGETING CD38 AND TGF-BETA

ANTI-TGF-BETA ANTIBODIES AND THEIR USE

ANTI-TGF-BETA ANTIBODIES AND THEIR USE

TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS

TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS

RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE

Adenoviral vectors having a protein IX deletion

Adenoviral vectors having a protein IX deletion

Adenoviral vectors having a protein IX deletion

ADENOVIRAL VECTORS HAVING A PROTEIN IX DELETION

Adenoviral vectors having a protein IX deletion

Gene therapy using replication competent targeted adenoviral vectors

RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE

Adenoviral vectors having a protein IX deletion

Diagnostic and treatment methods involving the cystic fibrosis tran...

Recombinant adenoviral vector and method of use

Adenoviral vectors having a protein IX deletion

Adenoviral vectors having a protein IX deletion

Adenoviral vectors having a protein IX deletion

Adenoviral vectors having a protein IX deletion

Recombinant adenoviral vectors and methods of use

Compositions and methods for inducing gene expression

Adenoviral vectors having a protein IX deletion

Adenoviral vectors having a protein IX deletion

Adenoviral vectors having a protein IX deletion

Methods of treating diabetes and other blood sugar disorders

Adenoviral vectors having a protein IX deletion

Gene therapy using replication competent targeted adenoviral vectors

Adenoviral vectors having a protein IX deletion